LYMPHOMA TREATMENT IN DEVELOPING COUNTRIES

Hodgkin's lymphoma in developing countries: can we go further?☆

Hodgkin’s lymphoma (HL) is a B cell malignancy that affects approximately 8000 new patients in the United States annually.1 This is the most common lymphoma affecting the young population with a higher incidence at ages 15 to 35 years. Because of its particular histological features and biological behavior, HL is highly responsive to chemotherapy and radiation, and therefore is considered a mod...

Is asthma treatment affordable in developing countries?

BACKGROUND A study was undertaken to assess whether the therapeutic aspects of published international asthma management guidelines are practically applicable in developing countries. METHODS Questionnaires were sent to expatriate doctors working in developing countries. RESULTS Forty one replies were received from 24 countries in Africa and Asia. Oral salbutamol was prescribed "usually" or...

[Treatment of acute asthma in developing countries].

Treatment of childhood pneumonia in developing countries

Definition of community acquired pneumonia (CAP) CAP can be defined clinically as the presence of signs and symptoms of pneumonia in a previously healthy child due to an acute infection (of less than 14 days’ duration) of the lower respiratory tract (usually occurs below terminal bronchioles) leading to cough or difficult breathing, tachypnoea, or lower chest-wall indrawing, which has been acqu...

Control of Rheumatoid Arthritis in Developing Countries

بیماری روماتیسم قلبی یکی از شایعترین علل مرگ و میر ناشی از بیماریهای قلبی و عروقی در کشورهای در حال توسعه می باشد. براساس بررسیهای انجام شده، میزان شیوع بیماری در جامعه و مدارس از ۱ الی ۲۲ در هر هزار نفر کودک می باشد. تخمین زده میشود که تعداد مبتلایان به بیماریهای مزمن روماتیسم قلبی در کشورهای در حال توسعه ۳۰ میلیون و در کشورهای صنعتی ۱ / ۵ میلیون باشد. بسیاری از موارد مرگ و میر ناشی از این بیم...